ES2390052T3 - Agonistas del receptor opioide kappa que comprende un derivado de 2-fenilbenzotiazolina - Google Patents

Agonistas del receptor opioide kappa que comprende un derivado de 2-fenilbenzotiazolina Download PDF

Info

Publication number
ES2390052T3
ES2390052T3 ES03715569T ES03715569T ES2390052T3 ES 2390052 T3 ES2390052 T3 ES 2390052T3 ES 03715569 T ES03715569 T ES 03715569T ES 03715569 T ES03715569 T ES 03715569T ES 2390052 T3 ES2390052 T3 ES 2390052T3
Authority
ES
Spain
Prior art keywords
acetyl
compound
methoxyphenyl
benzothiazoline
propoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03715569T
Other languages
English (en)
Spanish (es)
Inventor
Maki Tokai
Takahiro Honda
Masashi Niwa
Yaeko Osumi
K. Fujimura
Shin-Ichi Kohno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2390052T3 publication Critical patent/ES2390052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
ES03715569T 2002-03-29 2003-03-28 Agonistas del receptor opioide kappa que comprende un derivado de 2-fenilbenzotiazolina Expired - Lifetime ES2390052T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002097500 2002-03-29
JP2002097500 2002-03-29
PCT/JP2003/003928 WO2003082840A1 (en) 2002-03-29 2003-03-28 κ-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE

Publications (1)

Publication Number Publication Date
ES2390052T3 true ES2390052T3 (es) 2012-11-06

Family

ID=28671920

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03715569T Expired - Lifetime ES2390052T3 (es) 2002-03-29 2003-03-28 Agonistas del receptor opioide kappa que comprende un derivado de 2-fenilbenzotiazolina

Country Status (10)

Country Link
US (2) US7112598B2 (US20060205796A1-20060914-C00073.png)
EP (2) EP2042173A3 (US20060205796A1-20060914-C00073.png)
JP (1) JP5061134B2 (US20060205796A1-20060914-C00073.png)
KR (1) KR101035931B1 (US20060205796A1-20060914-C00073.png)
CN (2) CN1642929B (US20060205796A1-20060914-C00073.png)
AU (2) AU2003220894B8 (US20060205796A1-20060914-C00073.png)
CA (1) CA2480560C (US20060205796A1-20060914-C00073.png)
ES (1) ES2390052T3 (US20060205796A1-20060914-C00073.png)
NZ (1) NZ535987A (US20060205796A1-20060914-C00073.png)
WO (1) WO2003082840A1 (US20060205796A1-20060914-C00073.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1642590A4 (en) * 2003-07-04 2009-05-13 Santen Pharmaceutical Co Ltd MEANS TO INHIBIT THE DEGRADATION OF THE PAIN LIMIT
US7642274B2 (en) 2004-07-02 2010-01-05 Santen Pharmaceutical Co., Ltd. Inhibitor of pain threshold decrease
US20100130737A1 (en) * 2005-02-18 2010-05-27 Takeda Pharmaceutical Company Limited Regulating Agent of GPR34 Receptor Function
US9303027B2 (en) 2010-07-19 2016-04-05 Dr. Reddy's Laboratories Ltd. Kappa opioid receptor agonists
AU2013230425B2 (en) 2012-03-05 2017-05-25 Dr.Reddy's Laboratories Ltd. Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists
WO2014148574A1 (ja) 2013-03-22 2014-09-25 参天製薬株式会社 Il-2産生抑制
JP6531330B2 (ja) 2013-12-18 2019-06-19 国立大学法人京都大学 疼痛に関する化合物及び医薬組成物
US11433090B2 (en) 2017-06-16 2022-09-06 The Doshisha mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
US20200121652A1 (en) 2017-06-16 2020-04-23 The Doshisha Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US547513A (en) * 1895-10-08 Chell
JPS4994667A (US20060205796A1-20060914-C00073.png) * 1973-01-23 1974-09-09
JPS5846079A (ja) 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類
JPS5967276A (ja) 1982-09-01 1984-04-16 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
JPS60139679A (ja) 1983-12-27 1985-07-24 Santen Pharmaceut Co Ltd 2−アリ−ルベンゾチアゾリン誘導体
JPS6183175A (ja) 1984-09-06 1986-04-26 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体およびそれを主成分とする循環器官用薬剤
JPS62221679A (ja) 1986-03-19 1987-09-29 Santen Pharmaceut Co Ltd ベンゾチアゾリン誘導体
JPH066581B2 (ja) 1986-03-19 1994-01-26 参天製薬株式会社 フエノキシアルキルアミン側鎖を有するベンゾチアゾリン誘導体
JPH08231399A (ja) 1995-02-23 1996-09-10 Shionogi & Co Ltd モルヒネ禁断抑制作用剤
CN1291717C (zh) 1996-11-25 2006-12-27 东丽株式会社 止痒药物
JP2000344821A (ja) 1999-06-01 2000-12-12 Toagosei Co Ltd オレフィン重合用触媒

Also Published As

Publication number Publication date
KR101035931B1 (ko) 2011-05-23
CA2480560C (en) 2011-02-15
AU2009201233A1 (en) 2009-04-23
EP1496053B1 (en) 2012-06-20
CN100522954C (zh) 2009-08-05
EP2042173A2 (en) 2009-04-01
AU2003220894B2 (en) 2009-02-05
WO2003082840A1 (en) 2003-10-09
CN1642929A (zh) 2005-07-20
AU2009201233B2 (en) 2012-07-05
EP1496053A4 (en) 2008-01-16
AU2003220894A1 (en) 2003-10-13
EP1496053A1 (en) 2005-01-12
CN1911918A (zh) 2007-02-14
NZ535987A (en) 2006-08-31
KR20040095329A (ko) 2004-11-12
JP5061134B2 (ja) 2012-10-31
JP2009143940A (ja) 2009-07-02
US7112598B2 (en) 2006-09-26
US20060205796A1 (en) 2006-09-14
EP2042173A3 (en) 2010-02-24
US7410987B2 (en) 2008-08-12
US20050113430A1 (en) 2005-05-26
CA2480560A1 (en) 2003-10-09
CN1642929B (zh) 2010-05-12
AU2003220894B8 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
AU2009201233B2 (en) Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
ES2276530T3 (es) Azabiciclos qu4e modelan la inhibicion de la adherencia celular.
US6197824B1 (en) Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
KR20020015722A (ko) 환상 아민 ccr3 길항제
ES2220043T3 (es) Derivados del indol y composiciones medicinales que los contienen.
US6706753B2 (en) Integrin receptor inhibitors
ES2235383T3 (es) Beta-alaninas sustituidas.
US4460771A (en) Antiphlogistic and anticoagulant condensed pyrimidine derivatives
HU193333B (en) Process for production of 2-amino-axazilons and medical preparatives containing thereof
KR100636481B1 (ko) 피롤리딘카보닐아미노 환상 디설파이드
JP2010095550A (ja) キノリン誘導体
KR20020065916A (ko) Mtp 억제제로서 치환된 피페라진 유도체
JP4296345B2 (ja) 2−フェニルベンゾチアゾリン誘導体
JP2004002352A6 (ja) 2−フェニルベンゾチアゾリン誘導体からなるκオピオイド受容体アゴニスト
ES2356306T3 (es) Compuestos y fármacos derivados de piperidina que contienen los compuestos como principio activo.
JP2005526054A (ja) 化合物
WO1991008199A1 (en) Amino acid derivative
US4495189A (en) Condensed pyrimidines
PT765322E (pt) Derivados indole pro-farmacos de agonistas de receptores tipo 5-ht1
HU184896B (en) Process for producing new 3-alpha-amino-substituted-steroide derivatives
ITMI950964A1 (it) Nitroesteri di derivati aromatici di salicilammide e tiosalicilammide